Equillium, Inc. (EQ)
NASDAQ: EQ · Real-Time Price · USD
1.890
-0.030 (-1.56%)
Apr 8, 2026, 11:48 AM EDT - Market open
Equillium Employees
Equillium had 35 employees as of December 31, 2024. The number of employees decreased by 9 or -20.45% compared to the previous year.
Employees
35
Change
-9
Growth
-20.45%
Revenue / Employee
n/a
Profits / Employee
-$639,943
Market Cap
119.50M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 35 | -9 | -20.45% |
| Sep 30, 2024 | 45 | 0 | - |
| Jun 30, 2024 | 45 | -2 | -4.26% |
| Mar 31, 2024 | 44 | 7 | 18.92% |
| Dec 31, 2023 | 44 | 8 | 22.22% |
| Sep 30, 2023 | 45 | 0 | - |
| Jun 30, 2023 | 47 | 2 | 4.44% |
| Mar 31, 2023 | 37 | -10 | -21.28% |
| Dec 31, 2022 | 36 | -9 | -20.00% |
| Sep 30, 2022 | 45 | 0 | - |
| Jun 30, 2022 | 45 | - | - |
| Mar 31, 2022 | 47 | 16 | 51.61% |
| Dec 31, 2021 | 45 | 14 | 45.16% |
| Dec 31, 2020 | 31 | 15 | 93.75% |
| Sep 30, 2020 | 26 | 10 | 62.50% |
| Jun 30, 2020 | 22 | 6 | 37.50% |
| Mar 31, 2020 | 22 | 7 | 46.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Karyopharm Therapeutics | 228 |
| Sangamo Therapeutics | 183 |
| Innate Pharma | 163 |
| Agenus | 81 |
| PepGen | 56 |
| Genelux | 26 |
| AN2 Therapeutics | 21 |
| Black Diamond Therapeutics | 21 |
EQ News
- 3 hours ago - Equillium Announces Poster Presentations at IMMUNOLOGY2026™, the Annual Meeting of the American Association of Immunologists - GlobeNewsWire
- 5 days ago - Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 13 days ago - Equillium Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate and Clinical Highlights - GlobeNewsWire
- 21 days ago - Equillium to Participate in the 38th Annual Roth Conference - GlobeNewsWire
- 26 days ago - Equillium Announces $35 Million Financing with RA Capital Management - GlobeNewsWire
- 6 weeks ago - Equillium to Participate in the Leerink Partners 2026 Global Healthcare Conference - GlobeNewsWire
- 4 months ago - Equillium to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 5 months ago - Equillium Reports Third Quarter 2025 Financial Results and Provides Operational Update - GlobeNewsWire